Zobrazeno 1 - 10
of 156
pro vyhledávání: '"Noe Kyeong Kim"'
Autor:
Im Il Na, Do Yeun Kim, Byung Su Kim, Jee Hyun Kim, Young Whan Kim, Se-Hoon Lee, Yung-Jue Bang, Sung Koo Han, Yo Han Joh, Noe Kyeong Kim, Tae-You Kim, Choon Taek Lee, Chul Gyu Yoo, Young Soo Shim, Dae Seog Heo, Do Youn Oh
Publikováno v:
Cancer research and treatment. 33(5)
PURPOSE Platinum-based chemotherapy has conferred a modest but significant survival benefit and the introduction of newer drugs has led to achieve higher response rate in patients with advanced non-small cell lung cancer (NSCLC). We performed a phase
Autor:
Hyo-Jin Kim, Joo Young Jung, Won Seop Lee, Jae-Hoon Lee, Jun Seok Kim, Hyun Chul Jeong, Jun O Park, Dae Seog Heo, Noe Kyeong Kim, Ki-Hyun Kim, Sung-Soo Yoon, Yung-Jue Bang
Publikováno v:
Cancer research and treatment. 33(6)
PURPOSE Paclitaxel is a very effective agent in the treatment of breast cancer. Samyang Corporation has developed its own process to produce paclitaxel in a large volume using plant cell culture technology. To evaluate the efficacy and safety of Gene
Autor:
Young-Woo Kim, In Hae Park, Sun Young Kim, Jong Seok Lee, Jun Ho Lee, Sook Ryun Park, Keun Won Ryu, Young-Iee Park, Noe Kyeong Kim
Publikováno v:
Cancer Chemotherapy and Pharmacology. 67:127-136
Although gastric cancer with isolated para-aortic lymph node (PAN) involvement is considered an advanced disease, the clinical characteristics of it have not been comprehensively elucidated.We reviewed the medical records of 1,277 patients received p
Autor:
Byoung Kook Kim, Dae Seog Heo, Noe Kyeong Kim, Tae-You Kim, Chul Woo Kim, Yung-Jue Bang, Sunhoo Park, Dong Wan Kim, Seock-Ah Im, Sung-Soo Yoon, Byoung-Kwon Kim
Publikováno v:
Annals of Oncology. 20:121-128
Background: Many patients with extranodal natural killer/T-cell lymphoma (NTCL) fail to the front-line therapy and need an effective second-line chemotherapy. Patients and methods: This was single-institutional, phase II study. The primary end point
Autor:
Seock-Ah Im, Kuk Jin Choe, Mi-Na Kim, Woo Ho Kim, Dae Seog Heo, Kuhn-Uk Lee, Tae Min Kim, Han-Kwang Yang, Dong Wan Kim, Yu Jung Kim, Yung-Jue Bang, Noe Kyeong Kim, Tae-You Kim
Publikováno v:
Cancer Investigation. 26:152-158
Pathologic stage is the most important predictive factor of relapse in gastric cancer after curative resection. However, patients with the same stage often have different risks of relapse. Here, we investigated whether the expressions of molecular ma
Autor:
Noe Kyeong Kim, D.S. Heo, Cheolwon Suh, Baek-Yeol Ryoo, J.S. Kim, Sj Lee, J-S Lee, S-W. Kim, Dae Ho Lee, Kwang Bo Park, Je-Hwan Lee
Publikováno v:
Annals of Oncology. 19:123-127
Background Belotecan (Camtobell®, Chong Keun Dang Corp, Seoul, Korea; CKD602) is a new camptothecin analogue. This study aimed to investigate the safety and efficacy of single-agent belotecan for small-cell lung cancer (SCLC). Patients and methods T
Autor:
Dong Wan Kim, Dae Seog Heo, Se-Hoon Lee, Tae-You Kim, Yung-Jue Bang, Do Youn Oh, Seock-Ah Im, Jee Hyun Kim, Noe Kyeong Kim
Publikováno v:
Supportive Care in Cancer. 15:631-636
To better understand current practice relating to artificial nutrition/hydration in terminal cancer patients, we enrolled terminal cancer patients who were admitted at Seoul National University Boramae Hospital for supportive care only and who died w
Autor:
Yung-Jue Bang, Seock-Ah Im, Ji Yeon Baek, Yoon Kyung Jeon, Noe Kyeong Kim, Tae-You Kim, Dong Wan Kim, Chul Woo Kim, Dae Seog Heo, Sook Ryun Park
Publikováno v:
Journal of Korean Medical Science
Despite advances in the characterization of anaplastic large cell lymphoma (ALCL), little data is available on Asian patients. We report here upon single Korean institution's experience regarding the clinical characteristics and outcomes of ALCL. We
Autor:
Dae Seog Heo, Do-Youn Oh, Noe Kyeong Kim, Seock-Ah Im, Jee Hyun Kim, Yung-Jue Bang, Tae-You Kim, Dong Wan Kim
Publikováno v:
European Journal of Cancer Care. 15:74-79
The purpose of this study is to document infection and to better understand current practice relating to antibiotic use and its effect in terminal cancer patients. We retrospectively reviewed patients with terminal stage cancer who were admitted to S
Autor:
Byoung Kook Kim, Keun-Wook Lee, Yung-Jue Bang, Dae Seog Heo, Seock-Ah Im, Dong Wan Kim, Noe Kyeong Kim, Sung-Soo Yoon, Tae-You Kim, Seonyang Park, Tak Yun
Publikováno v:
Leukemia & Lymphoma. 47:1274-1282
Although most patients diagnosed with extranodal NK/T-cell lymphoma (NTCL) have localized disease, radiotherapy alone is unsatisfactory because of frequent systemic failure and conventional doxorubicin-based chemotherapy has low efficacy. Twenty-six